Coronary restenosis is a medical phenomenon marked by the re-narrowing or blockage of coronary arteries subsequent to an initial medical intervention like angioplasty or the placement of a stent to address coronary artery disease. While these interventions initially succeed in restoring blood flow to the heart, the recurrence of symptoms, such as chest pain or angina, indicates the onset of restenosis. This condition is primarily attributed to the re-growth of tissue within the treated artery, referred to as neointimal hyperplasia, or the reappearance of atherosclerotic plaque. The development of coronary restenosis involves a complex interplay of factors, including patient-specific characteristics, procedural techniques employed during the initial intervention, and the types of devices used. Continuous efforts by researchers and clinicians are focused on devising strategies to mitigate the risk of restenosis. One such advancement includes the development of drug-eluting stents that release medication, aiming to inhibit excessive tissue growth in the treated arteries.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt